N端脑钠肽前体与川崎病超急性期冠状动脉扩张的预测
本研究回顾性评估2010年1月至2014年12月儿科急诊就诊的1月龄至15岁川崎病超急性期(发热≤4天)患者,比较有和无冠状动脉扩张(CAD)者的血清NT-proBNP水平,CAD由超急性期24小时内经胸超声心动图判定。共纳入109例,其中23例在24小时内TTE发现CAD。CAD组NT-proBNP中位数824.1 pg/ml(IQR 515.4-1570.0)显著高于无CAD组396.4 pg/ml(IQR 184.8-767.8)(p≤0.001)。预测CAD的cutoff值为515.4 pg/ml,灵敏度78.26%、特异度61.63%,AUC 0.749(95%CI 0.642-0.856)。作者认为血清NT-proBNP可能作为儿科急诊川崎病超急性期早期检测CAD的附加实验室标志物。
要点
- 川崎病超急性期(发热≤4天)CAD组血清NT-proBNP中位数824.1 pg/ml,显著高于无CAD组396.4 pg/ml(p≤0.001)。
- 预测超急性期CAD的NT-proBNP cutoff值为515.4 pg/ml,灵敏度78.26%、特异度61.63%。
- NT-proBNP预测超急性期CAD的AUC为0.749(95%CI 0.642-0.856)。
- 研究为回顾性评估,109例中23例在超急性期24小时内TTE发现CAD。
- 作者认为NT-proBNP可能作为儿科急诊川崎病超急性期早期检测CAD的附加实验室标志物。
适用人群与场景
- 1月龄至15岁、在儿科急诊就诊的川崎病超急性期(发热≤4天)患者,且在超急性期24小时内接受经胸超声心动图检查。
诊断标准与关键阈值
- 冠状动脉扩张(CAD)由超急性期24小时内经胸超声心动图判定。
- 血清NT-proBNP预测超急性期CAD的cutoff值为515.4 pg/ml。
研究设计与关键结果
- 研究类型:回顾性评估电子病历,时间2010年1月至2014年12月31日,纳入109例,其中23例在超急性期24小时内TTE发现CAD。
- CAD组血清NT-proBNP中位数824.1 pg/ml(IQR 515.4-1570.0) vs 无CAD组396.4 pg/ml(IQR 184.8-767.8),p≤0.001。
- NT-proBNP cutoff值515.4 pg/ml预测超急性期CAD,灵敏度78.26%、特异度61.63%。
- NT-proBNP预测超急性期CAD的AUC为0.749(95%CI 0.642-0.856)。
证据类型、等级与局限
- 证据类型:回顾性评估电子病历。
- 作者结论:血清NT-proBNP可能作为儿科急诊川崎病超急性期早期检测CAD的附加实验室标志物。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为血清NT-proBNP可能作为儿科急诊川崎病超急性期(发热≤4天)早期检测CAD的附加实验室标志物。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Coronary artery dilatation (CAD) is a great concern with Kawasaki disease (KD). This study aimed to investigate the relationship between serum N-terminal pro-brain natriuretic peptide (NT-proBNP) levels and CAD in patients with the hyperacute phase (≤4 days of fever) of KD.
METHODS: Serum NT-proBNP levels were compared between patients with and those without CAD, who underwent transthoracic echocardiography (TTE) within 24 h of the hyperacute phase of KD in the pediatric emergency department (PED). Electronic medical records of patients aged 1 month to 15 years who visited the PED were retrospectively assessed from January 2010 to December 31, 2014.
RESULTS: One hundred nine patients were enrolled in the study. Twenty-three of those patients had CAD within 24 h of TTE. Median serum NT-proBNP levels were significantly higher in patients with CAD (824.1 pg/ml; interquartile range [IQR], 515.4-1570.0184.8-767.8 pg/ml) than in patients without CAD (396.4 pg/ml; IQR, 184.8-767.8 pg/ml) (p ≤ 0.001). The cutoff value of serum NT-proBNP, which predicted CAD during the hyperacute phase of KD, was 515.4 pg/ml, which yielded sensitivity of 78.26% and specificity of 61.63%. The area under the curve for NT-proBNP for predicting CAD during hyperacute KD was 0.749 (95% CI, 0.642-0.856).
CONCLUSION: Serum NT-proBNP might be an additional laboratory marker for detecting early CAD during the hyperacute phase of KD in the PED.
参考来源
- Jung JY, Ham EM, Kwon H, et al. N-terminal pro-brain natriuretic peptide and prediction of coronary artery dilatation in hyperacute phase of Kawasaki disease. Am J Emerg Med. 2018. PMID: 29903669. doi:10.1016/j.ajem.2018.06.021
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。